ARCpoint

TSXV-ARC
TSX Venture Exchange
Other
Global Rank
#43722
Country Rank
#1790
Market Cap
5.15 M
Price
0.0438
Change (%)
0.00%
Volume
0

ARCpoint's latest marketcap:

5.15 M

As of 07/26/2025, ARCpoint's market capitalization has reached $5.15 M. According to our data, ARCpoint is the 43722th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 5.15 M
Revenue (ttm) 4.27 M
Net Income (ttm) 2.3 M
Shares Out 128.36 M
EPS (ttm) 0.02
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/25/2025
Market Cap Chart
Data Updated: 07/26/2025

ARCpoint's yearly market capitalization.

ARCpoint has seen its market value drop from C$17.85 M to C$7.06 M since 2022, representing a total decrease of 60.45% and an annual compound decline rate (CAGR) of 30.22%.
Date Market Cap(C$) Market Cap(USD) Change (%) Global Rank
07/26/2025 C$7.06 M $5.15 M -29.52% 43722
12/31/2024 C$10.02 M $6.96 M 24.7% 39604
12/22/2023 C$8.03 M $6.06 M -55% 39029
12/28/2022 C$17.85 M $13.17 M 34760

Company Profile

About ARCpoint Inc.

ARCpoint Inc. operates as a franchise-based provider of drug, alcohol, DNA, and clinical lab testing and screening services across the United States. The company is structured into two primary segments: ARCpoint Franchise and AFG Services.

Core Services

  • Clinical Healthcare: Viral testing (Flu, Strep, COVID), regulatory compliance testing, and preventive care services.
  • Preventive Care: Annual health, heart health, thyroid, diabetes, and hormone testing.
  • Nutritional Testing: Food allergy/sensitivity and vitamin/nutrient deficiency assessments.
  • Specialty Health Solutions: TB and titer, pregnancy, respiratory, and blood type testing, along with vaccine and supplement injections.

Additional Offerings

  • Drug & Alcohol Testing: EtG, marijuana, PEth, unknown substances, and on-site mobile testing.
  • DNA Services: Paternity and genetic testing.
  • STD & Dry Eyes Testing: Comprehensive screening services.

Employer Solutions

  • DOT compliance solutions.
  • Background screening and HR employment services.
  • Corporate wellness programs.

Support Services

The company also delivers marketing, technology, and training support to its franchise network and clients.

Client Base

ARCpoint serves individuals, corporations, legal professionals, and healthcare providers.

Corporate Background

Originally founded in 1998 as RSI International Systems Inc., the company rebranded to ARCpoint Inc. and is headquartered in Greenville, South Carolina.

Frequently Asked Questions

  • What is ARCpoint's (TSXV-ARC) current market cap?
    As of 07/26/2025, ARCpoint (including the parent company, if applicable) has an estimated market capitalization of $5.15 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • ARCpoint global market capitalization ranking is approximately 43722 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.